Skip to main content
Livermore
Livermore
ZHEN

ProShare Advisors LLC

SEC CIK
0001357955
Latest filing
Aug 11, 2026

IBRX holding history

ImmunityBio, Inc. in every 13F filed by ProShare Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

IBRX overviewAll 13F holders of IBRXFull Q2 2026 holdings

Shares (Q2 2026)
84,964
Value
$743.9K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of IBRX by ProShare Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202684,964$743.9K<0.1%−3,805−4.3%ReducedHolders
Q1 202688,769$680.9K<0.1%−8,671−8.9%ReducedHolders
Q4 202597,440$192.9K<0.1%+24,434+33.5%AddedHolders
Q3 202573,006$179.6K<0.1%−7,122−8.9%ReducedHolders
Q2 202580,128$211.5K<0.1%+14,105+21.4%AddedHolders
Q1 202566,023$198.7K<0.1%−7,750−10.5%ReducedHolders
Q4 202473,773$188.9K<0.1%+5,261+7.7%AddedHolders
Q3 202468,512$254.9K<0.1%+8,059+13.3%AddedHolders
Q2 202460,453$382.1K<0.1%−10,160−14.4%ReducedHolders
Q1 202470,613$379.2K<0.1%+6,004+9.3%AddedHolders
Q4 202364,609$324.3K<0.1%+19,981+44.8%AddedHolders
Q3 202344,628$75.4K<0.1%+2,080+4.9%AddedHolders
Q2 202342,548$118.3K<0.1%+4,185+10.9%AddedHolders
Q1 202338,363$69.8K<0.1%−5,278−12.1%ReducedHolders
Q4 202243,641$221.3K<0.1%+944+2.2%AddedHolders
Q3 202242,697$212.0K<0.1%+2,510+6.2%AddedHolders
Q2 202240,187$150.0K<0.1%−14,004−25.8%ReducedHolders
Q1 202254,191$304.0K<0.1%−16,719−23.6%ReducedHolders
Q4 202170,910$431.0K<0.1%−21,404−23.2%ReducedHolders
Q3 202192,314$899.0K<0.1%+5,983+6.9%AddedHolders
Q2 202186,331$1.23M<0.1%+62,807+267.0%AddedHolders
Q1 202123,524$558.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.